Monday, 22 July 2019

BioLargo Engineering Awarded U.S. Air Force Subcontracts


Westminster, CA – July 22, 2019 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that its engineering subsidiary has been awarded two subcontracts to provide air quality environmental engineering services to five United States Air Force (USAF) bases in Texas and Arizona.

BioLargo Engineering, Science & Technologies (BLEST; www.BioLargoEngineering.com) has entered into a series of “teaming agreements” with Bhate Environmental Associates, Inc. (www.bhate.com), as prime-contractor, to prepare bids for submission to the U.S. General Services Administration (GSA) for environmental services on Air Force bases throughout the country. Bhate assembled a multi-disciplined team of five companies, including BLEST, to provide services to the USAF in what is commonly referred to as “fence-to-fence environmental services” call orders.  These fence-to-fence (F2F) projects include a menu of environmental engineering services, which focus on hazardous waste, hazardous materials, air quality, water quality, natural and cultural resources.

The total value of these two contracts awarded to Bhate exceeds $12 million over a five-year term, of which the subcontractors will receive a portion (first year guaranteed, and GSA can extend for four additional years). In addition to these awarded contracts, BLEST is working closely with Bhate to pursue similar environmental projects for the USAF which are in various stages of bids and consideration.

Randall Moore, President of BioLargo Engineering commented, “Our team has significant experience and expertise in this particular area of practice, and we are proud to serve our country and the US Air Force. We look forward to working hand-in-hand with Bhate on these first contracts as well as future successful bids.”

Dennis P. Calvert, President of BioLargo, Inc. commented, “These government contracts validate the wisdom of adding Randy and his team of engineering professionals to the BioLargo family of companies. Our investments in technologies and talent continue to pay off.”

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


Thursday, 18 July 2019

EPA Awards $2.3 Million in Funding for 21 Small Businesses to Develop Innovative Environmental Technologies

Source - US EPA: https://www.epa.gov/newsreleases/epa-awards-23-million-funding-21-small-businesses-develop-innovative-environmental

BioLargo Engineering was one of 21 companies awarded an EPA SBIR Phase I grant as announced today in the EPA's press release. BioLargo's grant will fund efforts to find technical solutions to PFAS contamination in water. You can read our own press release about our project HERE.

Read the EPA's press release in its entirety below!

********************

EPA Awards $2.3 Million in Funding for 21 Small Businesses to Develop Innovative Environmental Technologies

07/18/2019
Contact Information: 
EPA Press Office (press@epa.gov)
WASHINGTON — Today, the U.S. Environmental Protection Agency (EPA) announced $2.3 million in funding for 21 small businesses to develop technologies that will help protect human health and the environment by monitoring air quality, treating drinking water, cleaning up contaminated sites, and creating greener, less toxic materials.
“These funds support small businesses that have developed new technologies to monitor air quality, test for PFAS, and address other pressing environmental challenges,” said EPA Administrator Andrew Wheeler. “Through EPA’s Small Business Innovation Research program, we provide important assistance to entrepreneurs as they develop innovative solutions that will strengthen both environmental protections and economic growth.” 
These 21 small businesses are receiving Phase I contracts from EPA’s Small Business Innovation Research (SBIR) program, which awards contracts annually through a two-phase competition. Companies compete for a Phase I award of up to $100,000 by submitting research that addresses key environmental issues. After receiving a Phase I award, companies are eligible to compete for a Phase II award of up to $300,000 to further develop and commercialize the technology.
SBIR Phase I recipients include:
  • Creare LLC, Hanover, N.H., AirQAST Portable Automated Air Quality Monitoring
  • Anfiro, Inc., Woburn, Mass., Block Copolymer Membranes for Total Removal of Ionic and Nonionic PFAS from Industrial Wastewaters Optionally Co-Contaminated by Alcohols
  • Brisea Group, Inc., Parsippany, N.J., Development of Microwave-assisted Membrane Filtration for Pretreatment of PFAS in Industrial Wastewater
  • AAPLasma LLC, Feasterville, Pa., Non-Thermal Plasma Assisted Inactivation of Antibiotic Resistant Bacteria in Wastewater
  • Framergy Inc., Wilmington, Del., Innovative Pretreatment Technologies for PFAS in Industrial Wastewater
  • Mainstream Engineering Corporation, Rockledge, Fla., Field-deployable Measurement of Fluorocarbons in Water
  • PTP Strategy LLC, Gainsville, Fla., CDD-SORT: A Next-Generation System to Detect Hazardous & Recyclable Materials in Discarded C&D Debris
  • Faraday Technology Inc., Englewood, Ohio, Electrochemical Pretreatment of PFAS-Contaminated Aqueous Effluents; Electrochemical Extraction and Remediation of PFAS in Soils
  • Talk About It Solutions DBA Remooble, Maple Grove, Minn., Fast Acting Bio-Derived and Bio-Degradable Paint Removers for Epoxy, Latex and Lacquer Coatings
  • Claros Technologies Inc., Stillwater, Minn., Novel Sorbent Technology for Simultaneous Removal and Degradation of Waterborne PFAS
  • Polykala Technologies LLC, San Antonio, Texas, Development of “Smart” Polymer Nanofiber Mats for Selective and Efficient Removal of PFAS from Landfill Leachate 
  • TDA Research Inc., Wheat Ridge, Colo., Disposable Test Strips for Ultra-Sensitive Quantification of Polyfluoroalkyl Substances in Ground Water; Development of a Non-Toxic Paint Stripper
  • Sporian Microsystems Inc., Lafayette, Colo., Low Cost Hyperspectral Measurement System to identify Harmful Materials in Construction and Demolition (C&D) Materials
  • Oxbyel Technologies, Inc., Mesa, Ariz., Electrochemical Mineralization of PFAS in Industrial Wastewater
  • QuakeWrap, Inc., Tucson, Ariz., Trenchless Water Main Point Repairs with SuperLaminate
  • 2W iTech LLC, San Diego, Calif, Rapid Field Trace Detection of Perfluoroalkyl Substance in Water
  • BioLargo, Inc., Westminster, Calif., Aqueous Electrostatic Concentrator to Remove Per-and Poly-fluroakyl Substances from Water
  • KWJ Engineering Incorporated, Newark, Calif., Ultralow Power Sensor Package for Ground Level Air Pollution Levels from Wildland Fires
  • MicroAeth Corporation DBA AethLabs, San Francisco, Calif., Black Carbon and UV Particulate Matter, Multi-Gas, Multi Pollutant Sensor Platform
  • Intellisense Systems, Inc., Torrance, Calif., Remote Air Quality Reporting (RAQR) Device
  • Enoveo USA, Berkeley, Calif., The NODE biosensor: real-time contaminant detection in stormwater
     
EPA’s SBIR funding supports both the economy and the environment by creating jobs and promoting small businesses to bring environmental technologies to market. One EPA SBIR small business, GreenTechnologies, LLC, is commercializing a sustainable and innovative treatment and nutrient recovery process for wastewater. Their processes recover nutrients such as phosphorus, carbon and nitrogen in wastewater and convert the excess nutrients into sustainable slow-release fertilizers, branded under the name GreenEdge®, which are being sold commercially throughout the country and internationally.
EPA is one of 11 federal agencies that participate in the SBIR program, enacted in 1982 to strengthen the role of small businesses in federal research and development, create jobs, and promote U.S. technical innovation. To be eligible, a company must be an organized, for-profit U.S. business and have fewer than 500 employees.
Learn more about EPA’s SBIR program at www.epa.gov/sbir and learn about the current open Phase 1 SBIR solicitation, which closes on July 31, at www.epa.gov/sbir/sbir-funding-opportunities
Learn more about the federal SBIR program at www.SBIR.gov.

Tuesday, 9 July 2019

BioLargo Spotlight: Update on the AOS Poultry Pilot


Blog Post Update on AOS Poultry Pilot

Today we bring you an important and very positive update on our poultry wastewater demonstration pilot for our clean water technology – the AOS. In May we announced that our Water Technology division (www.biolargowater.ca) had designed, built, and delivered a sophisticated pilot water treatment train featuring our Advanced Oxidation System (AOS) at a poultry and livestock farm near Edmonton, AB called Sunworks Farm. You can see the pictures from the install at our blog post here. This demonstration pilot is a full treatment train containing everything a client needs to treat their wastewater to discharge standards set by regulators (in the US these are set by the US EPA) and even treat that water to water reuse standards that would allow the poultry farm to re-purpose the treated water for use in equipment and facility cleaning, thereby reducing the operation’s water usage and reduce the contaminants commonly found in their waste water. This is the first of our demonstration pilots, and we have another running right now at a Southern Californian microbrewery, with two more committed on the horizon.

We’re proud to say that our pilot AOS is operational now, and we have collected data showing that the AOS performs as predicted – eliminating contaminants from the poultry wastewater to the required standards. This is a critical milestone: we have real proof that BioLargo’s AOS delivers high performance poultry wastewater treatment in a real industry setting. As you can see in the picture below, treatment by the AOS train also results in a visible improvement to the water’s color! This is thanks to the multiple components in the AOS treatment train including the CFS system (coagulation, flocculation, sedimentation) spec'ed and installed by the BioLargo Water team - see a little video about this system HERE.




















This picture (below) indicates the success of the AOS’ disinfection performance in treating this highly contaminated wastewater. For those uninitiated in microbiology, the petri dish on the left is speckled with bacterial colonies, each of which came from a single bacterial cell in the water sample being tested. The science and engineering team collected countless samples to generate statistically significant data showing the AOS exceeded expectations in disinfection performance.




















We are often asked, what does the pilot work look like on a week-to-week basis for our scientists and engineers? Wastewater is produced from operations every Tuesday and remains in a holding tank within the facility. The wastewater is then drawn from the plant and treated over the course of the next 12 hours. Depending on the flowrate being tested this process may be completed in between 5 to 12 hours. Because this is a research pilot, every week new conditions are being tested, including different flowrates to optimize operational conditions. In the end, the goal is for the water that is treated by the AOS and the treatment train to be sufficiently clean to discharge and potentially reuse. This demonstration pilot represents a pivotal moment both for the AOS technology itself, and for the hardworking BioLargo Water R&D team developing this technology. For those unaware, a pre-commercial demonstration pilot is a crucial step in developing a new technology – especially one as complex as an advanced water treatment system. In this pilot our team is refining the technical offering of the AOS in a real commercial/industrial setting and refining the technology’s business model – wherein the AOS is offered as a portable, modular treatment train that solves a customer’s wastewater problems.

The BioLargo Water team has been dedicated to advancing the development of the AOS since the subsidiary’s inception in 2014, and this pilot is also the first field test not only of the AOS, but also of the team’s ability to deliver high performance water treatment results in a real field setting. In the pilot so far, they’ve certainly delivered, and we know they’ll exceed expectations. And as a reminder, our team is also currently executing on a demonstration pilot at a microbrewery in Southern California, and the technology is also being pulled by industry stakeholders for more pilots in areas like stormwater, food & beverage, and petrochemical.

Thursday, 13 June 2019

BioLargo’s CupriDyne Clean Eliminates Cannabis Odors - Third-Party Validated Study


Westminster, CA – June 13, 2019 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that a third-party study (download it HERE) had concluded its industrial odor control product CupriDyne® Clean eliminates “terpenes”, which cause the odors in cannabis grow and production facilities. Conducted by Southern Air Systems Corp (SAS) out of Knoxville Tennessee, the study analyzed the two key odor-causing terpenes: myrcene and limonene. In business since 1989, SAS personnel have more than 60 years of combined experience exclusively providing air quality services to the power, petroleum and chemical industries. The study concludes,

“After treatment with CupriDyne Clean, no trace of terpenes was detected in the air samples.”
BioLargo President & CEO Dennis P. Calvert commented, “This is a momentous day for CupriDyne Clean. Although field trials had already demonstrated that it was effective against odors caused by cannabis cultivation, this data set represents crucial scientific validation that should accelerate adoption of the product by cannabis and hemp industry operators. Many of the major players in the cannabis industry are scientifically minded, and third party validated data sets like this are crucial to earning their business.” 

Terpenes are highly odorous volatile organic compounds (VOCs) produced in cannabis cultivation and processing, and are known hazardous air pollutants when present at high concentration. In many jurisdictions Cannabis growers are required by regulators to enact air quality control measures to mitigate odor-causing terpenes at their operations (such as in Los Angeles County). The predominant solution currently used by the industry is carbon-based filters, which are expensive to purchase, install, and replace, and are widely known to be inadequate for handling the high volume of terpenes produced by industrial cannabis cultivation facilities. In order to comply with regulations and maintain good relations with neighbors, growers and processors in the booming cannabis market are seeking better active solutions to managing terpenes.

Joe Provenzano, President of BioLargo’s wholly owned subsidiary Odor-No-More, Inc. commented, “CupriDyne Clean is sold by a distributor to the industry under the Cannabusters brand (www.thecannabusters.com). These results increase our confidence in the product’s capacity to revolutionize odor control in the cannabis industry. Unlike many competitors, our product doesn’t just mask the odor-causing VOCs, it breaks them down through oxidation, meaning it is better at improving air quality. Our product is environmentally friendly, non-toxic, and a not a pesticide, making it an attractive solution for the cannabis industry.”



About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


Tuesday, 11 June 2019

BioLargo Spotlight: BioLargo Engineering Launches New Website


Since its addition to the BioLargo family in October 2017, BioLargo Engineering, Science & Technologies has played a central role in driving the product innovation and commercial capacity of BioLargo. Our engineering division has dramatically increased the variety of services we can offer our clients, bolstered the product and service offerings of our odor and VOC control division, and provided engineering and scale-up capabilities for the development of our clean water technology the AOS. Therefore, we are very happy today to unveil the new website of our engineering division, found at www.biolargoengineering.com.  








BioLargo Engineering’s new website is a tremendous upgrade from the company’s previous one, offering improvements not only in aesthetics but also in functionality, ease-of-use, and marketing potential. The timing of this website is ideal – our engineering division is ramping up its number of customer contracts and is offering expanded service packages to clients in specific areas where the division has special expertise. This includes areas like air quality control, water treatment and management, and cannabis industry-specific services. You can download the company’s abridged service listing in a brochure here.

As always, you can follow news about the BioLargo Engineering, including new service offerings, at BioLargo’s blog at www.biolargo.blogspot.com (that’s where you are now). If you want to catch up on notable posts about BioLargo Engineering, a good place to start is by looking at their posts about:
  • Cannabis services – LINK
  • Microbrewery services – LINK
  • Their recent EPA grant – LINK

You can also learn more about BioLargo Engineering at their website (who would have guessed?), where you can read case studies, articles, service listings, and learn about their past clients and projects.

Thursday, 6 June 2019

BioLargo is an Innovator and Solution Provider Hitting its Stride

Source: Tamarack Advisors via Accesswire

DENVER, CO / ACCESSWIRE / June 6, 2019 / BioLargo, Inc. (OTCQB: BLGO) is both an innovator of novel life sciences technologies and an environmental engineering services solutions provider, which is a rare combination for a company of its relatively small size. The company has a diverse portfolio of patented high-tech products, each driven by different subsidiaries focused on specific vertical segments. While each of these products is at a different stage in development or commercialization, each have recently hit critical development and/or commercialization milestones, making this a perfect time to revisit BioLargo.
The Edison Group, an investment research firm, recently released an update to their analysis on BioLargo titled "BioLargo Progresses Towards Independent Businesses". The report goes into detail about the commercial progress of BioLargo's CupriDyne® Clean products, medical products, and the AOS water treatment technology, and shows the substantial progress that the company has made towards its goal of establishing its subsidiaries as thriving independent businesses.
CupriDyne® Clean Continues to Penetrate Waste Handling Market and Cannabis Market Takes Notice of its Efficient Odor Control Solution
As BioLargo continues its long march towards profitability, the subsidiary leading the way in both revenue and product distribution is Odor-No-More, Inc., the makers of CupriDyne® Clean, an industrial odor eliminator currently in use by four of the top waste handling companies in the United States. CupriDyne® Clean has already been granted vendor status by these companies, which allows the product to expand beyond their regional test markets through national purchasing agreements. President & CEO of BioLargo Dennis P. Calvert elaborated further in a recent blog post stating, "In essence, we've proven to decision-makers at our national accounts that the product exceeds expectations and reduces costs, and consequently the product is being adopted in new regions held by our national account customers." Calvert goes on to say that the company has "new waste handling companies expressing interest in the product every week."
While the waste handling business is an enormous market, CupriDyne® Clean has also found a huge potential niche in the emerging cannabis market. With favorable legislation facilitating huge growth in the number of grow operations nationwide, odor and air pollutant control issues have moved to the forefront for regulators. Odor-No-More recently announced a five year white label agreement with Cannabusters, Inc., a subsidiary of the Mabre Corporation, to supply odor and VOC control products to cannabis production facilities. In just the past few days management also indicated in a series of interviews while presenting at the LD Micro conference that efforts continue to establish new distributors in this emerging market. With some projections for the cannabis industry to reach $35 billion by 2024, and 15,000 licensed California providers in BioLargo's backyard, Cupridyne® Clean has an opportunity to establish itself as the go-to solution in a major market in desperate need for odor control
AOS Water Treatment Platform Begins First Real-World Test
Last month BioLargo's Advanced Oxidation System (AOS) began its first in-field pre-commercial demonstration pilot, installing a system at the Sunworks Farm near Edmonton, Alberta. The unit consists of a "portable, modular water treatment solution that delivers the highest performance in disinfection and decontamination, eliminates hard-to-treat micropollutants, and has lower operational costs, capital costs, and energy usage rates than other similar water treatment technologies." The company's business model is to deliver AOS treatment trains as part of a free trial period, after which clients have the option of keeping the equipment through either lease, purchase, or pay-per-gallon.
This demonstration pilot for the AOS has numerous positive aspects. First, by providing the full system to an existing commercial poultry farm, they are able to record and measure key data points against existing historical norms at that farm. Second, they are able to take those metrics and provide analytics to potential customers, creating a "linchpin for future sales". Indeed, the most recent blog post from BioLargo states that they already have another pilot program being installed at a small brewery in Southern California.


Clyra Medical Nearing Conclusion of FDA 510(k) Process
BioLargo's Clyra Medical division is in the process of acquiring pre-market clearance for their first advanced wound care product. This product has several significant advantages over the technologies currently in use, including lower costs, gentleness as a result of its very low dosage of active ingredient, biofilm efficacy and extended antimicrobial protection. BioLargo recently reported it had a second in-person meeting with senior staff at the FDA, where they requested Clyra conduct a 30-day GLP animal study to confirm that the product has no adverse effects on wound healing. Clyra's management expressed confidence in positive results as they had already conducted a preliminary study. Since this was the final material request made by the FDA before a decision is to be made on the application, BioLargo now hopes to have a response back from the FDA in the July to August time frame, unless unexpected further information is requested by the FDA. It also acquired a patent-pending stem cell therapy technology in November (Skin Disc) and management indicates that it intends to acquire through licensing additional FDA-approved technologies as it prepares to go commercial with a portfolio of products focused on helping manage and heal chronic wounds. The addressable market for Clyra's disruptive wound care technology is projected to be $2.5 billion.


Conclusion
BioLargo has invested a decade and over $20 million to establish multiple commercially focused subsidiaries and corresponding patented technology-based products all centered around their proprietary iodine chemistry. CupriDyne® Clean is a product that has made serious inroads into the very traditional, but very large waste handling industry and is turning heads in the red-hot cannabis industry. The AOS water treatment technology recently began its first real world testing scenario as a low-cost water treatment device, and Clyra Medical is progressing with its 510(k) application. Beyond these potentially disruptive technologies, what makes BioLargo unique and well-equipped for growth compared to similar companies is its full-service engineering division which is serving external clients on a fee-for-service basis while simultaneously aiding BioLargo's other operating units to assist in their march toward commercial success.
Looking forward, BioLargo has the opportunity to succeed with a number of different product platforms. With increased sales, real world pilot programs, and the potential approval of their 510(k) application, this may be the time to consider investing in BioLargo, Inc. Management is quick to point out that it plans to expand its sales and marketing efforts, as capital is available, to serve these extremely large opportunities for its proven products and grow into the massive opportunities ahead.
Legal Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Flathead Business Solutions LLC, which owns tamarackadvisorsinc.com, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Flathead Business Solutions LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Flathead Business Solutions LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as ''expects,'' ''will,'' ''anticipates,'' and ''estimates''; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief ''snapshot'' of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.govwww.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with www.otcmarkets.com; (c) for Canadian listed stocks: www.tsx.com and orwww.sedar.com (d) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (e) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com. For full disclosure please visit http://tamarackadvisorsinc.com/legal-disclaimer/.
SOURCE: Tamarack Advisors

Wednesday, 5 June 2019

BioLargo's LD Micro Presentation for June 4, 2019




Here you can view the LD Micro Presentation that BioLargo CEO Dennis P. Calvert delivered yesterday, June 4th at the 9th annual LD Micro Investor Conference. As always, we relish the opportunity to allow all our stakeholders, stockholders, and followers to view this presentation in high resolution directly here at our blog. It's an exciting time at BioLargo, with multiple business units hitting critical milestones in development and commercialization of our patented, disruptive technologies.